abstract |
A composition for promoting ER-phage (ER-phagy), a composition for maintaining ER homeostasis or reducing ER stress, and a pharmaceutical composition for preventing and/or treating ER-stress-related diseases are provided, comprising a p62 ligand compound as an active ingredient . |